How many drugs treat Dysfunctional uterine bleeding?

Drug Landscape tracks 5 marketed treatments for Dysfunctional uterine bleeding (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/dysfunctional-uterine-bleeding.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Dysfunctional uterine bleeding — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dysfunctional uterine bleeding (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Dysfunctional uterine bleeding, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Aygestin	NORETHINDRONE ACETATE	Duramed Res	Estrogen [EPC]	Progesterone receptor	1973-01-01
Micronor	norethisterone	Johnson & Johnson	Progestin	GnRH receptors	1962-01-01
Endometrin	progesterone	Ferring	Progesterone [EPC]	Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1
Progesteron	Progesteron	Minia University		Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1
Depo-Provera	medroxyprogesterone	Pfizer	Progestin	Progesterone receptor	1959-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Duramed Res · 1 drug in Dysfunctional uterine bleeding
Ferring · 1 drug in Dysfunctional uterine bleeding
Johnson & Johnson · 1 drug in Dysfunctional uterine bleeding
Minia University · 1 drug in Dysfunctional uterine bleeding
Pfizer · 1 drug in Dysfunctional uterine bleeding

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Dysfunctional uterine bleeding:

Cite this brief

Drug Landscape (2026). Dysfunctional uterine bleeding — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/dysfunctional-uterine-bleeding. Accessed 2026-06-10.

Dysfunctional uterine bleeding full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing